Literature DB >> 3830252

Psychomotor impairment and anticonvulsant therapy in adult epileptic patients.

M J Brodie, E McPhail, G J Macphee, J G Larkin, J M Gray.   

Abstract

Using a battery of simple tests, psychomotor performance was assessed in 11 healthy subjects, 14 untreated epileptic patients and 66 epileptics on chronic anticonvulsant medication. Significant differences were found between controls and untreated patients for choice reaction time, card sorting and Simple Simon memory game. Treated patients performed less well than both untreated epileptics and controls in choice reaction time (p less than 0.05; p less than 0.001), card sorting (p less than 0.01; p less than 0.001), Simple Simon (p less than 0.05; p less than 0.001) and finger tapping (p less than 0.05; p less than 0.001). Patients with centrencephalic epilepsy were slower than those with discrete focal EEG abnormalities in reaction time and card sorting. Patients receiving treatment with carbamazepine, phenytoin or sodium valproate alone all performed similarly to each other and to those patients taking anticonvulsant polypharmacy. Monotherapy patients with potentially "toxic" plasma anticonvulsant concentrations did no worse than those within or below the "therapeutic" range. Both the disease and its treatment reduce psychomotor performance. All major anticonvulsants appear to cause a similar degree of impairment across a wide range of concentrations. The effect of chronic anticonvulsant medication on "quality of life" should not be neglected in the pursuit of perfect seizure control.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3830252     DOI: 10.1007/bf00541291

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Abilities and behaviour of epileptic children.

Authors:  H HALSTEAD
Journal:  J Ment Sci       Date:  1957-01

2.  Anticonvulsant drugs and mental symptoms: a review.

Authors:  M R Trimble; E H Reynolds
Journal:  Psychol Med       Date:  1976-05       Impact factor: 7.723

3.  Effects of paroxysmal spike-wave on continuous visual-motor performance.

Authors:  D J Goode; J K Penry; F E Dreifuss
Journal:  Epilepsia       Date:  1970-09       Impact factor: 5.864

Review 4.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

5.  Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.

Authors:  G J Macphee; E M McPhail; E Butler; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Memory function in focal epilepsy: a comparison of non-surgical, unilateral temporal lobe and frontal lobe samples.

Authors:  R C Delaney; A J Rosen; R H Mattson; R A Novelly
Journal:  Cortex       Date:  1980-03       Impact factor: 4.027

7.  Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy.

Authors:  P Thompson; F A Huppert; M Trimble
Journal:  Br J Clin Psychol       Date:  1981-09

Review 8.  Controlled trials in epilepsy: a review.

Authors:  L Gram; K D Bentsen; J Parnas; H Flachs
Journal:  Epilepsia       Date:  1982-10       Impact factor: 5.864

9.  Sodium valproate and cognitive functioning in normal volunteers.

Authors:  P J Thompson; M R Trimble
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

10.  Which drug for the adult epileptic patient: phenytoin or valproate?

Authors:  D M Turnbull; D Howel; M D Rawlins; D W Chadwick
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-16
View more
  13 in total

1.  Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests.

Authors:  T Kuitunen; M J Mattila; T Seppälä; K Aranko; M E Mattila
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

2.  Cognitive Adverse Effects of Antiepileptic Drugs : Incidence, Mechanisms and Therapeutic Implications.

Authors:  R Kälviäinen; M Äikiä; P J Riekkinen
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

3.  Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.

Authors:  J P Leach; J Girvan; A Paul; M J Brodie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

4.  Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients.

Authors:  J G Larkin; P J McKee; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

5.  Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy.

Authors:  R A Gillham; J Blacklaw; P J McKee; M J Brodie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

6.  More pronounced deficits in facial emotion recognition for schizophrenia than bipolar disorder.

Authors:  Vina M Goghari; Scott R Sponheim
Journal:  Compr Psychiatry       Date:  2012-12-04       Impact factor: 3.735

7.  Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic property.

Authors:  Guy A Higgins; Nathalie Breysse; Elijus Undzys; D Richard Derksen; Melanie Jeffrey; Brian W Scott; Tao Xin; Corinne Roucard; Karine Bressand; Antoine Depaulis; W M Burnham
Journal:  Psychopharmacology (Berl)       Date:  2009-10-16       Impact factor: 4.530

Review 8.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

9.  Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients.

Authors:  R A Gillham; N Williams; K Wiedmann; E Butler; J G Larkin; M J Brodie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

Review 10.  Impaired vigilance networks in temporal lobe epilepsy: Mechanisms and clinical implications.

Authors:  Dario J Englot; Victoria L Morgan; Catie Chang
Journal:  Epilepsia       Date:  2020-01-04       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.